G-FINDER data portal: tracking funding for global health R&D

The G-FINDER project tracks R&D funding for new products and technologies that address global health challenges disproportionately affecting the world's most disadvantaged populations. The G-FINDER data portal provides open access to all data captured by the G-FINDER project between 2007 and 2021 and is updated annually at the start of the year.

Distribution of funding across these STIs has remained relatively constant, with gonorrhoea receiving by far the most funding

Historically, around half of HPV R&D funding has gone to vaccines, and around a quarter to diagnostics

The peaks and troughs in MPT funding have been largely driven by changes in industry investment

While long-acting reversible contraception (LARC) funding decreased for the third consecutive year in FY21, it still accounted for 45% of total contraceptive funding

While funding for non-maternal heath SRH R&D has grown, investment in maternal health issues has declined